CTGF deficiency predisposes to aneurysm generation and rupture. Mineralocorticoid antagonist as potential therapeutic treatment.
| Autor: | Tejera-Muñoz, A., Rodrigues-Diez, R.R., Esteban, V., Steffensen, L.B., Rodrigues-Diez, R., Orejudo, M., Rayego-Mateos, S., Falke, L.L., Cannata-Ortiz, P., Ortiz, A., Egido, J., Mallat, Z., Briones, A.M., Selgas, R., Goldschmeding, R., Ruíz-Ortega, M. |
|---|---|
| Zdroj: | In Atherosclerosis August 2021 331:e246-e247 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect